Alkermes plc (ALKS)
NASDAQ·Healthcare·Biotechnology
$49.50
+0.01%
Mkt Cap $8.79B
Analyst Ratings
Buy
17
Hold
3
Sell
1
Price Target (28 analysts)
$52.60
Range $43.00 – $65.00
Implied Upside
+6.3%
Consensus $52.60 vs current $49.50
NASDAQ·Healthcare·Biotechnology
$49.50
+0.01%
Mkt Cap $8.79B
Buy
17
Hold
3
Sell
1
Price Target (28 analysts)
$52.60
Range $43.00 – $65.00
+6.3%
Consensus $52.60 vs current $49.50